- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 285/32 - 1,2,4-ThiadiazinesHydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 3
Patent holdings for IPC class C07D 285/32
Total number of patents in this class: 6
10-year publication summary
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Solent Therapeutics, LLC | 4 |
2 |
| Alla Chem, LLC | 55 |
1 |
| Getz Pharma Research Pvt. Ltd. | 1 |
1 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 849 |
1 |
| IVACHTCHENKO, Alena Alexandrovna | 15 |
1 |
| Other owners | 0 |